These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 8634430)
1. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430 [TBL] [Abstract][Full Text] [Related]
2. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons. Andrews RG; Winkler A; Myerson D; Briddell RA; Knitter GH; McNiece IK; Hunt P Stem Cells; 1996 Nov; 14(6):661-77. PubMed ID: 8948024 [TBL] [Abstract][Full Text] [Related]
4. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor. Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288 [TBL] [Abstract][Full Text] [Related]
5. Effects of Mpl ligands on platelet production and function in nonhuman primates. Harker LA; Marzec UM; Kelly AB Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183 [TBL] [Abstract][Full Text] [Related]
6. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization. Arnold JT; Daw NC; Stenberg PE; Jayawardene D; Srivastava DK; Jackson CW Blood; 1997 Feb; 89(3):823-33. PubMed ID: 9028313 [TBL] [Abstract][Full Text] [Related]
7. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Harker LA; Roskos LK; Marzec UM; Carter RA; Cherry JK; Sundell B; Cheung EN; Terry D; Sheridan W Blood; 2000 Apr; 95(8):2514-22. PubMed ID: 10753829 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Farese AM; Hunt P; Boone T; MacVittie TJ Blood; 1995 Jul; 86(1):54-9. PubMed ID: 7795256 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic cytokine stimulation of thrombocytopoiesis. Harker LA Transfus Sci; 1998 Jun; 19(2):149-62. PubMed ID: 10187040 [TBL] [Abstract][Full Text] [Related]
10. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis. Neumann TA; Foote M Cytokines Cell Mol Ther; 2000 Mar; 6(1):47-56. PubMed ID: 10976539 [TBL] [Abstract][Full Text] [Related]
11. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Ulich TR; del Castillo J; Yin S; Swift S; Padilla D; Senaldi G; Bennett L; Shutter J; Bogenberger J; Sun D Blood; 1995 Aug; 86(3):971-6. PubMed ID: 7620187 [TBL] [Abstract][Full Text] [Related]
12. Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia. Tomer A Blood; 2002 Mar; 99(5):1602-9. PubMed ID: 11861274 [TBL] [Abstract][Full Text] [Related]
13. Platelets in thrombotic disorders: quantitative and qualitative platelet disorders predisposing to arterial thrombosis. Harker LA Semin Hematol; 1998 Jul; 35(3):241-52. PubMed ID: 9685170 [TBL] [Abstract][Full Text] [Related]
14. The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice. Ulich TR; del Castillo J; Senaldi G; Cheung E; Roskos L; Young J; Molineux G; Guo J; Schoemperlen J; Munyakazi L; Murphy-Filkins R; Tarpley JE; Toombs CF; Kaufman S; Yin S; Nelson AG; Nichol JL; Sheridan WP Exp Hematol; 1999 Jan; 27(1):117-30. PubMed ID: 9923450 [TBL] [Abstract][Full Text] [Related]
15. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874 [TBL] [Abstract][Full Text] [Related]
16. Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia. McDonald TP; Cottrell MB; Steward SA; Clift RE; Swearingen CJ; Jackson CW Exp Hematol; 1992 Jan; 20(1):51-6. PubMed ID: 1577094 [TBL] [Abstract][Full Text] [Related]
17. Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Corash L; Chen HY; Levin J; Baker G; Lu H; Mok Y Blood; 1987 Jul; 70(1):177-85. PubMed ID: 3593965 [TBL] [Abstract][Full Text] [Related]
18. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors. Rasko JE; O'Flaherty E; Begley CG Stem Cells; 1997; 15(1):33-42. PubMed ID: 9007220 [TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin derived from human embryonic kidney cells stimulates an increase in DNA content of murine megakaryocytes in vivo. McDonald TP; Jackson CW Exp Hematol; 1990 Aug; 18(7):758-63. PubMed ID: 2199205 [TBL] [Abstract][Full Text] [Related]